本实验为进一步研究应用RNA干扰技术抗肿瘤治疗奠定基础。
Our research is important for further study of anti-tumor treatment with RNA interference.
组蛋白赖氨酸去甲基化酶有可能成为一个新的抗肿瘤治疗靶标。
Therefore, histone lysine demethylases may serve as a new target for anti-cancer therapy.
对照组患者及健康志愿者各10例，不给予抗肿瘤治疗而仅进行随访。
The other 10 patients as well as 10 healthy volunteers did not receive any anti-cancer treatment.
正常组织中产生广泛细胞死亡，形成了抗肿瘤治疗中最经常出现的副作用。
Widespread cell death in these tissues is responsible for the most common adverse effects of anticancer radiation therapy.
本文综述了VEGF及其受体的分类、作用机制及在抗肿瘤治疗中的应用。
The classification, mechanism and application of VEGF and VEGFR in anti-tumor therapy are reviewed.
结论：脂质体是抗肿瘤药物的理想载体，在抗肿瘤治疗中有广泛的应用前景。
Conclusion: Liposome is an ideal carrier of antitumor drugs. It has extensive prospect in antitumor therapy.
因此应用药物促使肿瘤启动细胞凋亡程序，就成为抗肿瘤治疗的一个有意义与希望的研究领域。
Therefore a meaningful and hopeful field of anti-tumor treatment study is applying medicine to start the tumor cell apoptosis process.
然而，对于唑来膦酸与其他抗肿瘤治疗合用的最佳方案和剂量、持续时间还需要进一步的研究。
However, some important questions remain, including optimal dosing, initiation and duration of therapy, to be studied in further investigations.
本文提出，应该以促使肿瘤细胞坏死、诱导机体抗肿瘤免疫反应为抗肿瘤治疗的主导思想和研究方向。
The benefit of inducing apoptosis is not to cause inflammatory reaction, but as its disadvantage, it inhibits immune responses, and th…
本文从树突状细胞的来源、分化成熟、抗原提呈机理及抗肿瘤治疗的实验研究、临床应用等方面进行综述。
In this review, we summarize the source, differentiation, antigen presenting mechanism, the experimental and clinical researches on anti tumor therapy of dendritic cells.
开展化疗专项护理和心灵关怀护理服务，让患者对抗肿瘤治疗有正确的认识，消除患者对治疗的恐惧心理。
Also we conduct specially spiritual care to eliminate patient's fear for chemotherapy, so that patients can fight against cancer with a correct understanding and a high confidence.
然而，无论是抗肿瘤治疗开始后的整体生存率，还是吉非替尼治疗后无恶化生存率在上述两组病人中并无明显差异。
However, neither overall survival after the start of antitumor therapy nor progression-free survival after gefitinib therapy was significantly different between groups.
百分之五十的人认为绝大多数艾滋病患者正在接受治疗。而事实是，去年只有五分之一的艾滋病人得到了抗肿瘤治疗。
And 50% of people overall believed that most patients diagnosed with HIV are currently receiving treatment, when in fact only one in five of such patients received antiretroviral therapy last year.
血管内皮细胞生长因子(VEGF)及其受体在肿瘤血管新生中起重要作用，阻断VEGF的生成已成为抗肿瘤治疗的新靶点。
Vascular endothelial growth factor (VEGF) and its receptor play a critical role in tumor-associated angiogenesis and have become the new targets of anti-tumor therapy.
本发明的长链烃基取代苯酚类化合物可作为细胞周期抑制剂、细胞凋亡诱导剂、细胞增殖抑制剂和抗肿瘤剂用于抗肿瘤治疗。
The disclosed compounds can be used as cell cycle inhibitor, cell apoptosis inducer, cell proliferation inhibitor and antineoplastic agent in tumor-resisting treatment.
包括单克隆抗体、酪氨酸激酶抑制剂、融合蛋白、瘤苗在内，以her2为靶点的抗肿瘤治疗研究成为热点，并显示出广阔的应用前景。
Anticancer therapies targeting HER2 have shown promise and become a focus, including monoclonal antibody, tyrosine kinases inhibitor, tumor vaccine, fusion protein.
羟基脲是一种抗肿瘤药，也可以用来治疗镰状细胞性贫血。
A cancer drug called hydroxyurea (Droxia, Hydrea) also is used to treat sickle cell anemia.
与传统细胞毒化疗不同，肿瘤靶向治疗具有特异性抗肿瘤作用，并且毒性明显减少。
In contrast to conventional cytotoxic chemotherapy, targeted cancer therapy possess specific anticancer effects and less toxicity.
番茄红素抗肿瘤特性的不断被揭示，将为乳腺癌预防和治疗提供一种新的安全有效的思路。
Lycopene anti-cancer properties of constantly be revealed, for breast cancer prevention and treatment will provide a new security effective thinking.
基于PTEN功能，目前时兴的依赖于免疫系统抗肿瘤的治疗方法可能更有效果或效果较差。
Emerging therapies that rely on the immune system to fight cancer could potentially be more or less effective based on PTEN function.
结论CD 105可以作为新生血管的标记物用于抗肿瘤血管形成的研究和治疗。
ConclusionCD105 may be used as a new marker of neovascularization in the research and treatment of anti-tumor angiogenesis.
长久以来，研究者们一直困惑于一个谜题：为什么一些备受推崇的抗肿瘤新药对许多常见肿瘤的治疗效果只能达到10%到20%？
Researchers have long been puzzled by the fact that some of medicine's most touted new cancer drugs work only 10% to 20% of the time against many common tumors.
从传统的中草药这些天然物质中寻找安全有效的抗肿瘤药物是目前肿瘤治疗研究的一个热点。
It is a hotspot for tumor treatment research to look for safe and effective anti-tumor drugs from traditional Chinese herbal medicine.
结论：IL - 2或TNF肝癌特异性原位基因治疗介导免疫抗肿瘤反应，但机理有所不同。
Conclusion: In situ hepatoma-specific gene therapy with IL-2 and TNF gene mediates anti-hepatoma immune response, but the mechanisms seem different.
这些结果显示，使用此方法的过继性T细胞治疗的的安全性，可行性和潜在抗肿瘤活性。
These results show the safety, feasibility, and potential antitumor activity of adoptive T-cell therapy using this approach.
这些结果显示，使用此方法的过继性T细胞治疗的的安全性，可行性和潜在抗肿瘤活性。
These results show the safety, feasibility, and potential antitumor activity of adoptive T-cell therapy using this approach.
应用推荐